Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).

Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol. 1996 Oct; 23(5 Suppl 12):40-7.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Cyclophosphamide
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Paclitaxel
Prospective Studies
Salvage Therapy

authors with profiles

Michael H. Davidson